Skip to main content
Log in

Evaluation of cutaneous algogenic responses to bradykinin and inhibition by bradykinin analogs

  • Original Contribution
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Summary

Bradykinin has long been postulated to have a major role in physiologic human pain production. We have developed a method to systematically quantify the algogenic response to bradykinin in human skin by the direct application of bradykinin to suction blister bases. After determination of the pain threshold to bradykinin, we examined the ability of synthetic peptide analogs of bradykinin to block bradykinin-induced pain. One of the six analogs (B4642) inhibited bradykinin-induced pain with at least one concentration in all subjects tested. This result could not be predicted on the basis of inhibition of bradykinin binding to its guinea-pig ileum receptor or to previous studies of bradykinin-induced pain production in animal models. This peptide may have an eventual role as a physiologic pain inhibitor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Armstrong D (1970) Pain. Handbook Exp Pharmacol 25:434–480

    Google Scholar 

  2. Armstrong D, Keele CA, Jepson JB, Stewart JW (1954) Development of pain-producing substance in human plasma. Nature 174:791–792

    Google Scholar 

  3. Clark WG (1970) Kinins and the peripheral and central nervous system. Handbook Exp Pharmacol 25 [Suppl]:311–356

    Google Scholar 

  4. Kiistala U, Mustakillo KK (1968) Dermoepidermal separation with suction. Electron microscopic and histochemical study of initial events of blistering of human skin. J Invest Dermatol 48:466–477

    Google Scholar 

  5. Manning DC, Vavrek RJ, Stewart JM, Snyder SH (1986) Two bradykinin binding sites with picomolar affinities. J Pharmacol Exp Ther 237:504–512

    Google Scholar 

  6. Mantione CR, Rodriquez R (1990) A bradykinin [BK] receptor antagonist blocks capsaicin-induced ear inflammation in mice. Br J Pharmacol 99:516–518

    Google Scholar 

  7. Sterank LR, Manning DC, Dehaas CJ, Ferkany JW, Borosky SA, Connor JR, Vavrek RJ, Stewart JM, Snyder SH (1991) Bradykinin as a pain mediator: Receptors localized to sensory neurons and analgesic actions of antagonists. Proc Natl Acad Sci USA (in press)

  8. Stewart JM, Vavrek RJ (1987) Bradykinin competitive antagonists: Design and activities. In: Barth A, Schowen RL (eds) Advances in biosciences, vol 65. Pergamon Journals, London

    Google Scholar 

  9. Vavrek RJ, Stewart JM (1985) Competitive antagonists of bradykinin. Peptides 6:161–164

    Google Scholar 

  10. Whalley ET, Clegg S, Stewart JM, Vavrek RJ (1987) The effect of kinin agonists and antagonists on the pain response of the human blister base. Naunyn-Schmiedeberg's Arch Pharmacol 336:652–655

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schneider, B.K., Morelli, J.G., Vavrek, R.J. et al. Evaluation of cutaneous algogenic responses to bradykinin and inhibition by bradykinin analogs. Arch Dermatol Res 284, 1–4 (1992). https://doi.org/10.1007/BF00371917

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00371917

Key words

Navigation